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Abstract Purpose: To report a case
of hypopyon uveitis associated with
systemic lupus erythematosus and
antiphospholipid antibody syndrome.
Methods: Interventional case report:
a 49-year-old woman with a history
of systemic lupus erythematosus and
antiphospholipid antibody syndrome
presented with sudden onset of pain,
redness, photophobia, and decreased
vision in the left eye. Examination
revealed hypopyon uveitis and vaso-
occlusive retinopathy. Results: Fol-
lowing treatment with intravenous
steroids and cyclophosphamide, the
patient’s vision improved from CF
to 20/80 with no inflammation 6
months following initial presentation.
Conclusions: In this case, systemic
lupus and antiphospholipid syn-
drome were associated with hypo-
pyon uveitis. Prompt treatment with
systemic immunosuppressive therapy
resulted in improvement in the hy-
popyon uveitis and vaso-occlusive
retinopathy.
Introduction
Systemic lupus erythematosus is commonly associated
with a microangiopathic retinopathy characterized by in-
traretinal hemorrhages and cotton-wool spots. Occasion-
ally, SLE and antiphospholipid antibody syndrome are
associated with a severe vaso-occlusive retinopathy or
choroidopathy [3, 4, 6]. To our knowledge, hypopyon
uveitis has not been reported in systemic lupus erythe-
matosus or antiphospholipid antibody syndrome.
Case report
A 49-year-old woman was referred to the Retina Service of the
Kellogg Eye Center. She had a 26-year history of systemic lupus
complicated by recurrent episodes of lower extremity vasculitis,
antiphospholipid antibody syndrome, polyarthralgias, and plaque-
nil-associated maculopathy. The patient complained of progressive
pain, redness, photophobia, and decreased vision in the left eye.
One week prior to presentation the patient had been hospitalized for
a lupus flare characterized by polyarthralgias and lower extremi-
ty vasculitis that was treated with pulse intravenous steroids. The
patient’s medications on discharge, 3 days prior to presentation,
included oral prednisone and azathioprine. On examination, best-
corrected visual acuity was 20/60 OD and CF at 6 in. (15 cm) OS.
The right eye was significant only for her baseline plaquenil-as-
sociated maculopathy. The left eye, however, showed moderate
conjunctival injection and chemosis with 3+ cells in the anterior
chamber and a layered hypopyon (Fig. 1a). The iris vessels were
sheathed with exudates and intrastromal hemorrhages (Fig. 1b).
Dilated retinal examination showed 3+ vitreous cells and 360 of
intraretinal hemorrhages, retinal edema, cotton-wool spots, and
arterial and venous sheathing (Fig. 2a). Fluorescein angiography
showed blockage of the choroidal fluorescence in the areas of the
retinal hemorrhages, severe capillary dropout, and late leakage
from inflamed vessels (Fig. 2b,c).
The patient was admitted to the hospital and started on intra-
venous methylprednisolone and aggressive topical steroid therapy.
Since hypopyon uveitis has not been reported to be associated with
systemic lupus erythematosus or antiphospholipid antibody syn-
drome, the diagnosis of Behcet’s disease was considered. Behcet’s
disease can be associated with antiphospholipid syndrome and is
characterized by hypopyon uveitis and occlusive vasculitis [1]. Our
patient was negative for HLA B5 and did not meet the International
Study Group criteria for Behcet’s disease. This suggested that the
hypopyon uveitis was a novel ocular manifestation of systemic
lupus. Magnetic resonance imaging of the brain did not reveal any
evidence of CNS vasculitis. In consultation with her rheumatolo-
gist, the patient was also started on intravenous cyclophosphamide.
One week following presentation the hypopyon had resolved. The
patient was discharged and received continued treatment with
monthly intravenous cyclophosphamide infusions. She tolerated a
slow taper of the oral and topical steroids. By 6 months her visual
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acuity had improved to her baseline of 20/80 without recurrence of
any intraocular inflammation.
Discussion
Vaso-occlusive retinopathy has been reported in patients
with systemic lupus erythematosus and antiphospholipid
antibody syndrome [4, 6]. In addition to retinopathy, lu-
pus has been shown to be associated with uveitis. The
proportion of the uveitis patients referred to a tertiary care
center over a 10-year period who had a diagnosis of lupus
was 4.8% [5]. Anticardiolipin antibodies are also more
commonly associated with occlusive retinopathy; how-
ever, there are reports of iritis, scleritis, filamentary ker-
atitis, and vitritis [2].
Given the novel finding of hypopyon uveitis in this
case, it is important to establish that the patient met the
diagnostic criteria for systemic lupus erythematosus. The
patient had a 26-year history of systemic lupus and was
followed up closely by our rheumatology clinic. Her lupus
was characterized by joint involvement, possible previ-
ous CNS vasculitis, glomerulonephritis with chronic renal
failure, positive ANA, positive antiRo and antidsDNA
antibody, persistent lymphopenia, and low C3 and C4
levels. The patient also had a history of antiphospholipid
antibody syndrome characterized by a markedly raised
DRVVT with mixing studies positive for coagulation
protein inhibitor. In addition, the patient test-ed positive
for IgM anticardiolipin antibody and IgM antibeta2GPI.
The presence of antiphospholipid anti- body syndrome
was further supported by a history of chronic thrombo-
cytopenia, false-positive VDRL, cognitive dysfunction,
mitral valve regurgitation consistent with Libman-Sachs
endocarditis, and deep venous throm-bosis. These findings
confirmed that the patient met the clinical diagnostic cri-
teria for lupus and strongly supported the diagnosis of
antiphospholipid antibody syndrome. Furthermore, our
patient did not meet the In- ternational Study Group di-
agnostic criteria for Behcet’s disease.
To our knowledge, this is the first reported case of
hypopyon uveitis seen in the setting of systemic lupus
erythematosus or antiphospholipid antibody syndrome.
This case demonstrates the importance of prompt system-
ic immunosuppressive therapy in controlling the ocular
manifestations of lupus.
Fig. 1 a anterior segment color
photograph showing layered
hypopyon and intrastromal iris
hemorrhages. b higher magni-
fication view of sheathed iris
vessels and intrastromal hem-
orrhages
Fig. 2 a Color fundus photo
showing intraretinal hemor-
rhages, edema, cotton-wool
spots, and arterial and venous
sheathing. b Late-phase fluo-
rescein angiograph showing se-
vere capillary dropout and late
leakage from inflamed vessels
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